|
|
||||||||
Ann Thorac Surg 2006;82:1784-1789
© 2006 The Society of Thoracic Surgeons
a Department of Surgery, Helsinki University Central Hospital, Helsinki, Finland
b Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
c Department of Infectious Disease Epidemiology, National Public Health Institute, University of Helsinki, Helsinki, Finland
Accepted for publication May 25, 2006.
* Address correspondence to Dr Eklund, HUCH, Jorvi Hospital, Department of Surgery, Turuntie 150, FIN-02740 Espoo, Finland (Email: anne.eklund{at}fimnet.fi).
| Abstract |
|---|
|
|
|---|
METHODS: We studied 10,713 consecutive patients who underwent open-heart surgery from 1990 to 1999 in a tertiary care university hospital using data prospectively recorded in the hospital discharge register, operating room log, and the hospital's cardiothoracic surgery unit register. Those cases with possible mediastinitis were identified from the hospital infection register and discharge register. Patients' charts were reviewed and cases of mediastinitis confirmed based on criteria of the Centers for Disease Control and Prevention.
RESULTS: The overall rate of mediastinitis was 1.1% (120 cases), and higher in coronary artery bypass surgery than in valvular surgery (1.2 vs 0.8%). No trend in incidence was detectable, although surgical patients became progressively older (mean age, 59 to 65 years, p < 0.01), and the proportion of women (from 25% to 31%; p < 0.01) and of patients with American Society of Anesthesiologists score over 3 (from 10% to 81%, p < 0.01) both increased. The rate of mediastinitis was almost twice as high in men (1.2% vs 0.7%, p < 0.01). In three body mass index (BMI) categories (<25, 25 to 30, and >30 kg/m2), rates of mediastinitis were 0.5%, 1.0%, and 1.8%. In multivariate analysis adjusted for age, sex, year, operation type, and perfusion time, the only predictor for mediastinitis was BMI.
CONCLUSIONS: Mediastinitis is not diminishing. Larger populations at risk, for example proportions of overweight patients, reinforce the importance of surveillance and pose a challenge in focusing preventive measures.
| Introduction |
|---|
|
|
|---|
The aim of this study was to assess incidence, predisposing factors, and outcome for mediastinitis in our patients in order better to understand aspects of this serious complication. We also evaluated whether any changes have occurred during the last decade.
| Material and Methods |
|---|
|
|
|---|
No major changes occurred in surgical techniques during this period. Until 1996, antibiotic prophylaxis was two doses of intravenous vancomycin (1 g and 500 mg) in 6 hours. From 1997, the coronary artery bypass grafting surgery (CABG) patients received antibiotic prophylaxis with two doses of intravenous cefuroxime 1.5 g in 6 hours. Patients who underwent valve reconstruction or were hospitalized at least 3 days preoperatively also received intravenous vancomycin 500 mg on two occasions. The staff reported all nosocomial infections to the hospital infection register, and infection control nurses confirmed them and entered them in the database.
Those cases with possible mediastinitis were identified from the hospital discharge register and the hospital infection register, from which were also gathered all cases with sternal wound infection and positive blood cultures. Then patients' charts were reviewed for cases of mediastinitis confirmed with criteria by the Centers for Disease Control and Prevention [9]. According to the CDC, mediastinitis must meet at least one of the following criteria: (1) a positive bacterial culture from the mediastinal space; (2) evidence of mediastinitis during a surgery or in histology; (3) one of the following: fever (>38°C), chest pain, or sternal instability; and at least one of the following: purulent discharge from the mediastinal area, organisms cultured from blood, or from the discharge from the mediastinal area, or mediastinal widening in radiology. Data collected in a retrospective chart review included type and timing of antibiotic prophylaxis, microbiologic cultures, radiologic findings, treatment, and reoperation for mediastinitis.
Statistical Analysis
Univariate analyses for categoric variables were calculated with the
2 test or the Fisher exact test, as appropriate and for continuous variables with the Mann-Whitney U test. Potential risk factors with p < 0.20 in univariate analysis and some potential confounding factors were included in multivariate analysis, which was performed as forward step-wise logistic regression. A p value less than 0.05 was considered statistically significant. Data were analyzed by SPSS for Windows version 12.0 (SPSS Inc, Chicago, IL).
| Results |
|---|
|
|
|---|
|
|
Microbiology
Microorganisms were isolated from 109 patients (Table 2). For 3 patients, the cultures were negative, for 4, cultures were not taken, and for another 4, information was missing. Superficial or drain cultures accounted for 61% of specimens, and invasive (mediastinal or blood) cultures for 39%. In 66 patients, the mediastinitis was caused by one pathogen, and in 43, more than one. Gram-positives were isolated from 82% cultures (1990 to 1996: 77% vs 1997 to 1999: 93%), and gram-negatives from 16% (1990 to 1996: 20% vs 1997 to 1999: 7%). The most commonly isolated pathogens were Staphylococcus epidermidis (78 patients, 65%) and Staphylococcus aureus (28 patients, 23%). Splitting the data according to the antibiotic regimens used (years 1990 to 1996 vs 1997 to 1999), S. epidermidis was isolated from 61% vs 73% patients and S. aureus from 23% vs 24%. Concomitant bacteremia was diagnosed in 24 cases (20%) and was most often caused by S. aureus (Table 2).
|
Comparing patients who underwent surgery for mediastinitis (n = 84) with those who did not (n = 36), in the surgery group the proportion of patients from whom S. aureus was isolated was significantly higher than in the nonsurgery group (26% vs 18%, p = 0.025). No difference appeared between these two groups as to time when mediastinitis was diagnosed or existence of concomitant bacteremia.
Risk Factors and Outcome
The operating room log showed the rate of mediastinitis to be zero in patients with ASA score 1-2 (0 of 91) and highest in those with ASA score 5 (2 of 25, 8.0%). It was, however, higher in patients with score 3 (19 of 1,294, 1.5%) than in those with score 4 (88 of 8,644, 1.0%). The mediastinitis rate was not significantly higher in patients with a National Nosocomial Infections Surveillance (NNIS) risk index score 2 or greater than in those with a score less than 2 (1.2% vs 1.0%, p = 0.38).
The rate of mediastinitis was higher in males (1.2% vs 0.7%, p < 0.01), and patients were not older than nonmediastinitis patients but had a higher BMI. Their operation times tended to be longer. In three BMI categories (<25, 25 to 30, and >30 kg/m2), the mediastinitis rate was 0.5%, 1.0%, and 1.8%, respectively. Of the variables entered into a multivariate logistic regression analysis (age, sex, BMI, operation year, perfusion time, type of procedure), only BMI was an independent risk factor (odds ratio [OR] 1.1, 95% confidence interval [CI] 1.05 to 1.15, p < 0.01) (Table 3).
|
| Comment |
|---|
|
|
|---|
The rate of mediastinitis we detected (1.1%) is in line with that of other large studies performed since the 1980s. Risk was slightly higher in CABG (1.2%) than in valvular surgery (0.8%). In the retrospective studies dated before 2000, mediastinitis varied between 1.0 and 2.3% [13, 10, 11]. Three prospective studies published more recently showed similar rates (0.7% to 1.4%) [5, 12, 13]. Some studies included only CABG procedures, and showed rates of mediastinitis of 0.7% to 2.3% [1, 2, 12, 14, 15]. In those studies that included all cardiac surgery, as did ours, rates of mediastinitis were also higher in CABG surgery than in valvular or other cardiac surgery (1.6% to 3.4% vs 0.7% to 1.7%) [4, 11, 16, 17].
Less than 1% of our patients with mediastinitis died within one month after cardiac surgery, and 9% died within one year. Between patients with and without mediastinitis, mortality did not differ. Increased early mortality has been associated with mediastinitis [1, 3, 5, 18], but a few studies also show increased long-term mortality [2, 12, 19]. Such differences may be related to the causative microbes. In two studies with mortality rates of 30% and 40%, the pathogens involved were mainly S. aureus and Pseudomonas aeruginosa [10, 14], but mediastinitis caused mainly by coagulase-negative staphylococci showed low mortality (2% to 4%) [4, 15, 20]. Among our mediastinitis patients, the most commonly isolated pathogen was S. epidermidis and then S. aureus. Pathogens involved in SSIs after cardiac surgery are usually S. epidermidis and S. aureus [16, 21, 22]. Coagulase-negative staphylococci have recently become the most important pathogen, especially in deep infections [21].
Clearly, treatment of mediastinitis is very expensive [1]. This was also evident in our study, because 70% of the patients had to be reoperated for mediastinitis, 14% underwent more than one operation, and the average hospital stay was more than one month.
Our only predictive factor for mediastinitis was obesity. Obesity has previously been shown to predispose not only to superficial sternal infection but also to mediastinitis [13, 15, 16, 18, 20, 23, 24]. Our rate of mediastinitis was also almost three times as high in patients with BMI greater than 30 as in those with BMI less than 25. Similarly, in a French study [16], the rate of mediastinitis was 5.6% with BMI 30 or greater, compared with 2.0% with BMI less than 30. Increased risk for mediastinitis in obese patients may be related to several factors such as technical difficulties during surgery, prolonged operation time, increased bleeding, and ineffective prophylactic antibiotic dose [2]. Overweight may also be associated with type II diabetes mellitus and metabolic syndrome. Several groups have observed an increased risk for mediastinitis among diabetics having cardiac surgery [1, 3, 4, 12, 14, 15, 18, 24, 25]. Of our mediastinitis patients, 21% had diagnosed diabetes. Due to incomplete documentation in postdischarge diagnoses and the cardiothoracic register, we could not, however, evaluate diabetes as a risk factor, nor had we systematic information on perioperative or postoperative glucose levels. More recent studies show that undiagnosed diabetes and postoperative hyperglycemia are also associated with development of SSIs, and that perioperative continuous intravenous insulin infusion can lower the incidence of deep sternal infection in diabetic patients in cardiac surgery [2527], a finding with important practical implications for prevention. These results were not available during our study period.
Antibiotics used in prophylaxis changed during the study period in 1997 without affecting the incidence of mediastinitis. However, the proportion of isolated gram-negative bacteria fell from 20% to 7%, reflecting the antibiotic regimen change from vancomycin to cefuroxime. Essentially, all our patients with mediastinitis (99%) received antimicrobial prophylaxis, but there is still room for improvement, especially in its timing. Of those who received prophylaxis, 13% did not receive it during the 60 minutes (120 minutes for vancomycin) before incision. Prior studies have demonstrated that timing is critical to the effectiveness of prophylaxis, and current guidelines recommend dosing within 60 minutes before incision [28]. More than half our patients received only vancomycin, most likely to cover methicillin-resistant coagulase-negative staphylococci. We found that vancomycin infusion was often initiated rather close to incision and that the dose might have been insufficient, especially in obese patients [29]. Data available in our operating room log included no information on type and timing of antimicrobial prophylaxis, so these could not be studied as a risk factor.
In our study, risk for mediastinitis did not increase along with ASA and NNIS risk scores. Roy and colleagues [30] also showed that duration of the procedure was the only component of the NNIS index that stratified the patients undergoing cardiothoracic operations by risk for SSI. Their study, however, included all SSIs, not only mediastinitis. The internal thoracic artery as graft material has proven superior to vein grafts, but use of both internal thoracic arteries in the same operation may increase infectious complications [1, 15, 16, 31]. In our patients who developed mediastinitis, we had used both internal thoracic arteries rarely (5%), and between patients with and without mediastinitis proportions did not differ.
Our patient population undergoing cardiac surgery during the last decade changed substantially. This was most likely due to the fact that an increasing number of patients had nonoperative cardiac procedures instead of CABG. Christakis and colleagues [32] found incidence of CABG-associated morbidity and mortality to increase along with the number of elderly patients, patients with previous CABG procedures, and patients undergoing urgent operations. We did not observe similar trends (although our patients got older) with an increasing proportion with ASA score 3 or 4. In addition, the proportion of females increased. This can, in part, explain our findings because risk for mediastinitis was lower in females. Previously, either gender had been one risk factor for SSI after cardiac surgery, depending on site and type of SSI [33]. Our male patients had a slightly higher BMI, but gender was not an independent risk factor in multivariate analysis. Age has been verified as a risk factor for SSIs in many types of surgeries [34, 35]. However, several cardiac surgical studies showed that age does not predispose to sternal infections [1, 4, 10, 11, 1517], which is consistent also with our findings.
Our study was based on a retrospective chart review and to evaluate the incidence and potential risk factors we utilized data uploaded from four separate in-hospital databases: the hospital discharge register, hospital infection register, operating room log, and a register kept by cardiothoracic surgeons. Linkage of several databases at the patient level was problematic, and only a limited number of variables could be included in our final analysis. For example, in addition to diabetes and blood glucose levels, several other known risk factors for infection, such as tobacco or concurrent corticosteroid use, could not be studied.
Our results indicate that the rate of mediastinitis is not decreasing. Changes in population at risk (for example, an increasing prevalence of overweight patients) reinforce the importance of surveillance and pose a continuous challenge in focusing preventive measures. Planning and selection of data fields entered and compulsory in various hospital information systems requires study of potential infection control interventions for more efficient disease prevention.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. P. Tocco, A. Costantino, M. Ballardini, C. D'Andrea, M. Masala, E. Merico, L. Mosillo, and P. Sordini Improved results of the vacuum assisted closure and Nitinol clips sternal closure after postoperative deep sternal wound infection Eur. J. Cardiothorac. Surg., May 1, 2009; 35(5): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schimmer, S.-P. Sommer, M. Bensch, T. Bohrer, I. Aleksic, and R. Leyh Sternal closure techniques and postoperative sternal wound complications in elderly patients. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 132 - 138. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |